✦ LIBER ✦

No Influence of V617F Mutation in JAK2 on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelofibrosis

✍ Scribed by Markus Ditschkowski; Ahmet H. Elmaagacli; Rudolf Trenschel; Nina K. Steckel; Michael Koldehoff; Dietrich W. Beelen

Book ID: 116279070
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 55 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.07.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clearance of the Janus kinase 2 (JAK2) V

Clearance of the Janus kinase 2 (JAK2) V617F mutation after allogeneic stem cell transplantation in a patient with myelofibrosis with myeloid metaplasia

✍ Guillermo J. Ruiz-Argüelles; Javier Garcés-Eisele; Virginia Reyes-Núñez; Guiller 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Eradication of JAK2 V617F mutation after

Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia

✍ Fiorini, A; Reddiconto, G; Farina, G; Marietti, S; Palladino, M; Chiusolo, P; Le 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Monitoring of the JAK2-V617F mutation by

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis

✍ Kroger, N.; Badbaran, A.; Holler, E.; Hahn, J.; Kobbe, G.; Bornhauser, M.; Reite 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 286 KB

Relapse of postpolycythemia myelofibrosi

Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

✍ Benjamini, O; Koren-Michowitz, M; Amariglio, N; Kroger, N; Nagler, A; Shimoni, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Evaluation of a JAK2 V617F quantitative

Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms

✍ Haslam, Karl; Molloy, Karen M.; Conneally, Eibhlin; Langabeer, Stephen E. 📂 Article 📅 2014 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 643 KB

Inferior Outcome With Addition Of Rituxi

Inferior Outcome With Addition Of Rituximab For Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Acute Lymphoblastic Leukemia (ALL)

✍ P. Kebriaei; M. Munsell; K. Gutierrez; M. de Lima; S. Giralt; C. Hosing; U. Popa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB